Market Overview

US Stock Futures Signal Lower Start On Wall Street

Share:
US Stock Futures Signal Lower Start On Wall Street
Related AAPL
Greenlight Capital At UBS: More Disappointment From August
Trip Chowdhry's View On The Upcoming Apple TV, Netflix And FoundationDB
Apple News Could Boost Which Chip Stocks? (Investor's Business Daily)
Related DGICA
Donegal Group Inc. CEO To Take Medical Leave Of Absence
Zacks Rank #1 Additions for Friday - Tale of the Tape

Pre-open movers

US stock futures fell in early pre-market trade, ahead of consumer credit data. Data on consumer credit for August will be released at 3:00 p.m. ET. Futures for the Dow Jones Industrial Average tumbled 131 points to 14,867.00, while the Standard & Poor's 500 index futures fell 16 points to 1,668.80. Futures for the Nasdaq 100 index dropped 27.75 points to 3,206.75.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index falling 0.76%, London's FTSE 100 index dropping 0.82% and STOXX Europe 600 Index declining 0.88%. German DAX 30 index fell 1.13% and French CAC 40 Index declined 1.01%.

Asian markets ended lower today. Japan's Nikkei Stock Average fell 1.22%, Australia's ASX/S&P500 dropped 0.87%, Hong Kong's Hang Seng Index fell 0.71% and India's Sensex dropped 0.10%.

Broker Recommendation

Analysts at Jefferies upgraded Apple (NASDAQ: AAPL) from “hold” to “buy.” The target price for Apple has been raised from $425 to $600.

Apple's shares gained 0.62% to $486.02 in pre-market trading.

Breaking news

  • Gregory Mark Shepard announced today that he has sent a letter to the Boards of Directors of Donegal Group (NASDAQ: DGICA) and Donegal Mutual Insurance Company ("Donegal Mutual") proposing an amicable transaction. To read the full news, click here.
  • ArcelorMittal (NYSE: MT) and Sider, an Algerian state-owned company, signed a strategic agreement on Saturday 5 October that includes an investment plan of US$763m for the steel complex at Annaba and the mines in Ouenza and Boukhadra. To read the full news, click here.
  • Cell Therapeutics (NASDAQ: CTIC) today announced that the company reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the planned pivotal Phase 3 clinical trial, known as the PERSIST-2 trial, evaluating pacritinib compared to best available therapy, including approved JAK2 inhibitors such as ruxolitinib, in patients with myelofibrosis whose platelet counts are <100,000/uL. To read the full news, click here.
  • Gemino Healthcare Finance today announced it has been acquired by Solar Senior Capital (NASDAQ: SUNS). To read the full news, click here.

Posted-In: Jefferies US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

 

Related Articles (AAPL + CTIC)

Get Benzinga's Newsletters